ask="90.00"
ask_size="5000"
average_daily_volume="609540"
bid="69.00"
bid_size="100"
book_value="9.90"
change="+2.77"
change_from_200_day_moving_average="22.70"
change_from_50_day_moving_average="16.30"
change_from_52_week_high="-0.64"
change_From_52_week_low="43.89"
change_in_percent="+4.11%"
close="70.17"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.75"
ebitda="-159.88M"
eps_estimate_current_year="-6.68"
eps_estimate_next_quarter="-1.64"
eps_estimate_next_year="-6.00"
ex_dividend_date="N/A"
float_shares="33738000"
high="70.81"
high_52_weeks="70.81"
last_trade_date="3/1/2017"
last_trade_price="70.17"
last_trade_size="30489"
last_trade_time="4:00pm"
low="67.13"
low_52_weeks="26.28"
market_capitalization="2.62B"
moving_average_200_day="47.47"
moving_average_50_day="53.87"
name="Sage Therapeutics
Inc."
notes="N/A"
one_year_target_price="83.08"
open="69.01"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+47.83%"
percent_change_from_50_day_moving_average="+30.27%"
percent_change_from_52_week_high="-0.90%"
percent_change_from_52_week_low="+167.01%"
previous_close="67.40"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="6.81"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="37270000"
short_ratio="8.74"
stock_exchange="NGM"
symbol="SAGE"
volume="626981"
weeks_range_52="26.28 - 70.81"
